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Background/Objectives: Nitric oxide (NO) has been proposed as a mediator of vascular expansion during pregnancy. Inability
to increase NO synthesis and/or production of its precursor, arginine, may be a contributor to pregnancy-induced hypertension
or preeclampsia. Because maternal weight is associated with blood pressure and risk of preeclampsia during pregnancy, it may
also influence arginine and/or NO production. The purpose of this study was to determine the in vivo arginine production and
NO synthesis rate in pregnant women with normal (n¼10) and low (n¼10) body mass indices (BMIs).
Subjects/Methods: Arginine flux and NO synthesis rate were measured in the postabsorptive state with constant infusions of
15N2-arginine and
13C,
2H4-citrulline. Plasma concentrations of arginine and NO metabolites were also measured. Kinetic
parameters were correlated to maternal variables, gestational age, birth weight and blood pressure.
Results: Endogenous arginine flux was significantly faster in the low-BMI compared with normal-BMI women in the first
trimester (63.1±3.4 vs 50.2±2.0mmol/kg per h, Po0.01), but not in the second. Plasma NO concentration was higher
(44.7±5.3 vs 30.4±1.9mmol/l, P¼0.03) and its rate of synthesis trended faster in the low-BMI compared with normal-BMI
group in the second trimester. Maternal weight and BMI were negatively correlated with arginine flux in both trimesters and NO
synthesis in the second trimester.
Conclusions: These findings suggest, but do not prove, that maternal BMI may be a factor in the ability to produce NO during
pregnancy and may be one way by which BMI influences blood pressure during pregnancy.
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Introduction
A physiological adaptation of pregnancy is expansion of the
maternal vascular compartment. It starts with vasodilatation
as peripheral resistance falls by 6 weeks and reaches a
minimum in mid-pregnancy (Walters et al., 1966; Mashini
et al., 1987; Robson et al., 1989). What initiates sustained
vasodilatation and thus blood volume expansion is poorly
understood. Increase in the production of prostaglandins,
particularly prostacyclin, may be one factor contributing to
the fall in peripheral vascular resistance (Poston et al., 1995;
Carbillon et al., 2000). In addition, nitric oxide (NO), which
is produced by the endothelium when arginine is converted
to NO and citrulline by the enzyme nitric oxide synthase
(NOS), is a vasodilator that downregulates vascular respon-
siveness to vasoconstrictors, such as angiotensin, in preg-
nancy (Walters et al., 1966; Mashini et al., 1987; Robson
et al., 1989). In an earlier study, we showed that both
arginine production and NO synthesis rose steeply in early
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EJCN EJCNOpenpregnancy in normal healthy women, providing additional
evidence that NO may have a function in vascular expansion
during pregnancy (Goodrum et al., 2003).
Inability to adequately increase arginine production and/or
NO synthesis may lead to pregnancy-induced hypertension.
However, human studies that have used circulating or
urinary concentrations of NO metabolites (nitrite and nitrate,
NOx) as indices of NO production have produced conflicting
results. Using this approach, NO production was found to be
higher, lower or unchanged in preeclamptic women com-
pared with normotensive women (Maul et al., 2003).
Maternal weight may be one factor affecting NO production
during pregnancy. A study of the influence of maternal pre-
pregnancy body mass index (BMI) on blood pressure found
that mean systolic blood pressure (SBP) was positively
associated with maternal pre-pregnancy BMI, and lean
women (BMI o20kg/m
2) had the lowest mean SBP in each
trimester (Miller et al., 2007). In epidemiological studies, low
BMI has been associated with decreased risk of preeclampsia
(Sebire et al., 2001; Bodnar et al., 2005; Bhattacharya et al.,
2007), and Bodnar et al. (2007) found a clear relationship
between pre-pregnancy BMI and the risk of preeclampsia. In
developing countries, such as India, underweight pregnant
women are more prevalent than in developed countries and
although low maternal BMI has been associated with adverse
outcomes in the fetus, including low birth weight (LBW) and
intrauterine growth retardation (Ehrenberg et al., 2003; Sahu
et al., 2007), it appears to be protective against preeclampsia.
The lower blood pressure and lower risk of preeclampsia seen
in women with low BMI may be due to an increased arginine
production facilitating a faster NO synthesis. In this study, we
tested the hypothesis that arginine flux and NO synthesis will
be faster in Indian pregnant women with low BMI compared
with those with normal BMI during early pregnancy and
mid-gestation. Using a stable isotope tracer technique, we
measured arginine flux and NO synthesis in two groups of
women with normal (BMI418.5 and p25kg/m
2) and low
(BMIp18.5kg/m
2) BMI at the end of the first and second
trimesters of pregnancy.
Subjects and methods
The study was conducted at the obstetrics ward of St John’s
Medical College Hospital, Bangalore, India. The experimen-
tal protocols were reviewed and approved by the institu-
tional ethical review board of St John’s Medical College
Hospital and by the institutional review board for Human
Subject Research of Baylor College of Medicine and affiliated
hospitals. A written consent was obtained from each subject
at enrollment.
Subjects
Subjects were recruited from pregnant women who were
below 13 weeks of gestation and registered for antenatal
screening at the Department of Obstetrics and Gynecology,
St John’s Medical College Hospital. Women with multiple
pregnancies, those with the clinical diagnosis of chronic
illness, such as diabetes mellitus, hypertension, heart disease,
thyroid disease, epilepsy, and those who tested positive for
hepatitis B surface antigen, HIV or syphilis were excluded.
Only subjects from the same dwelling area and similar
socioeconomic background were invited to join the study.
After a low-BMI (BMIp18.5kg/m
2) woman was identified, a
corresponding subject, matched closely for age and parity,
and with a normal BMI (BMI418.5 and p25kg/m
2) was
identified and invited to join the study. A total of 20
subjects, 10 with low BMI and 10 with normal BMI, were
enrolled for the study after screening (Clinical guide-
lines,1998). At recruitment, routine antenatal tests were
carried out.
Sociodemographic and anthropometric data
At the baseline visit information on age, obstetric history
and socioeconomic status was obtained from each subject.
Gestational age was assessed by ultrasonographic measure-
ments carried out within 2 weeks of the initial visit. A digital
balance (Soehnle, Germany) was used to record the weights
of all women to the nearest 100g, whereas height was
measured using a stadiometer to the nearest 1cm. Blood
pressure was measured with a digital sphygmomanometer
(HEM-757CAN; OMRON, Burlington, Canada).
Tracer infusion protocol
All subjects were studied in the postabsorptive state on two
occasions, at the end of the first trimester (12±1 weeks of
gestation) and the second trimester (24±1 weeks of gesta-
tion). Subjects were admitted to the obstetrics ward in the
evening and ate dinner, which was based on their habitual
diet, at 1900 hours. After 6h, an intravenous catheter (Jelco,
22G; Medex Medical Ltd, Lancashire, UK) was inserted into
the antecubital vein of one arm for the infusion of isotopes
whereas another catheter was inserted in the antiflow
direction into the dorsal vein of the contralateral hand for
drawing blood samples. The hand was heated to arterialize
venous blood samples.
Sterile solutions of
15N2-guanidino-arginine and
13C,
2H4-
citrulline (Cambridge Isotope Laboratories, Woburn, MA,
USA) were prepared in 9g/l NaCl. After a 5ml baseline blood
sample was collected, a primed, continuous infusion of
15N2-arginine (prime¼6mmol/kg, infusion¼6mmol/kg per
h) and
13C,
2H4-citrulline (prime¼1mmol/kg, infusion¼1m
mol/kg per h) was started and maintained for 6h. In
addition, the citrulline pool was primed with
15N-citrulline
(prime¼0.16mmol/kg). Three additional blood samples were
drawn at 15-min intervals during the last 45min of the
15N2-arginine and
13C,
2H4-citrulline infusions. At the end of
the infusions, the subjects were given breakfast and sent
home after a general medical checkup.
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The blood samples were drawn into prechilled tubes
containing sodium fluoride and potassium oxalate, centri-
fuged at 41C, and the plasma was removed and stored at
 801C. First, plasma arginine and citrulline were converted
to their 5-(dimethylamino)-1-napthalene sulfonamide
(DANS) derivatives. Briefly, 0.05ml of 0.1 M sodium tetra-
borate buffer was added to 0.1ml plasma and mixed by
vortex. Then, 0.1ml of 20mM DANS-Cl reagent was added,
mixed by vortex and allowed to stand for 30min. Proteins
were precipitated by adding 1.0ml of chilled (01C) aceto-
nitrile, mixing by vortex and allowing to stand on ice for
30min. After centrifugation in a high-speed Eppendorf
microcentrifuge at 10000r.p.m. for 10min, the supernatant
was removed and dried. The plasma arginine and citrulline
isotopic enrichments were measured by tandem liquid
chromatography–mass spectrometry using electrospray ioni-
zation and selected reaction monitoring at m/z 408–410 at
34eV for arginine and m/z 409–414 at 14eV for citrulline.
Plasma arginine concentrations were measured by stan-
dard ion-exchange chromatography. Plasma concentrations
of NO metabolites nitrite and nitrate (NOx) were measured
by in vitro isotope dilution as previously described by us
(Villalpando et al, 2006). Briefly, 0.5ml of the baseline
plasma sample was spiked with a known quantity of
Na
15NO3, the internal standard and the nitrate reduced to
nitrite. The isotopic enrichment was then determined by
negative chemical ionization gas chromatography–mass
spectrometry by selectively monitoring ions as m/z ratios of
46–47.
Calculations
Total arginine and citrulline flux (or rate of appearance, QArg
and QCit) were calculated by the steady-state equation:
Fluxðmmol=kg per minÞ¼ð IEInf=IEPlÞ i
where IEInf and IEPl are the isotopic enrichments of the tracer
in the infusate and in plasma at isotopic steady state (Mþ2
isotopomer for arginine and Mþ5 isotopomer for citrulline)
and i is the rate of infusion of
15N2-arginine or
13C,
2H4-
citrulline in mmol/kg per h.
Endogenous QArg was obtained by subtracting the rate of
infusion of labeled arginine. Whole-body arginine flux was
calculated as the product of endogenous flux and body
weight.
NO synthesis rate was calculated from the rate of
conversion of arginine to citrulline by the NO synthesis
reaction as previously described:
NOsynthesisðmmol=kg per hÞ¼QArg!Cit¼QCit IECit=IEArg
 ½QArg=IArgþQArg 
where QArg and QCit are the fluxes of arginine and citrulline,
IECit is the plasma enrichment of the Mþ1 isotopomer
of citrulline (that is, ureido-
15N-citrulline derived from
15N2-arginine), IEArg is the plasma enrichment of the Mþ2
isotopomer of arginine and IArg is the rate of infusion of
15N2-arginine.
Whole-body NO synthesis was calculated as the product of
NO synthesis and body weight.
Statistical analysis
Data are expressed as mean±s.e.m. Differences in subject
characteristics between the low- and normal-BMI groups
were assessed by unpaired t-test. The metabolic variables and
blood pressure were analyzed by mixed-model (repeated
measure two-factor) ANOVA. This model included the
groups (low and normal BMI) and trimesters (first
and second). Post hoc comparisons were performed using
Bonferroni’s test. Correlations between measured kinetic
variables and subject or baby characteristics were performed
for each group using Pearson’s correlation. The data from the
two groups were combined and the analysis repeated for all
subjects after a regression analysis showed that the slopes
of the groups were not different. Tests were considered
statistically significant if Po0.05. Data analyses were per-
formed with GraphPad Prism version 4 software (GraphPad
Software, San Diego, CA, USA).
Results
The low-BMI group had significantly lower weight and BMI
at the time of recruitment into the study (Table 1). Between
the groups, the increase in body weight (normal¼
3.26±0.62kg (from 49.1±1.3 to 52.3±1.4); low¼3.83±
1.34kg (from 42.3±0.9 to 46.1±0.76) and BMI (normal¼
1.53±0.28kg/m
2, low¼1.82±0.39kg/m
2)) from trimester
Table 1 Characteristics at recruitment and pregnancy outcomes of
normal- and low-BMI pregnant women
Normal BMI Low BMI
Age (years) 24.5±5.0 21.4±3.0
Primiparous 6 7
Weight (kg) 49.1±3.9 42.2±2.9
a
Height (cm) 151.4±3.4 153.3±5.1
BMI (kg/m
2) 21.46±1.73 17.93±0.69
a
Fat mass (kg) 14.4±2.6 9.2±1.8
a
Fat mass (%) 29.2±3.12 21.8±3.10
a
Fat-free Mass (kg) 34.7±1.7 32.9±1.5
a
Fat-free mass (%) 71±3.7 77.8±2.9
a
Hb (g/100ml) 12.34±0.86 11.85±1.72
Physical activity level 1.50±0.13 1.50±0.19
Gestational age at birth (weeks) 37.0±3.1 38.1±1.5
Baby birth weight (g) 2354±491 2639±326
Low birth weight (o2.5kg) 6 3
Abbreviations: BMI, body mass index; Hb, hemoglobin.
Values are mean±s.d., n¼10 per group; low BMI, BMIp18.5; normal BMI,
BMI418.5o25.
aPo0.001 by Unpaired t-test.
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parity, height and hemoglobin concentration between
groups. There were no significant differences in gestational
age at birth, and one mother of each group had a premature
delivery (35th and 36th week in the normal- and low-BMI
group, respectively), followed by death of the baby. Because
this occurred well after the trimester 2 experiment, their
arginine and NO kinetics data were included in the analysis.
Similarly, there were no significant differences in birth
weight, although the low-BMI mothers gave birth to babies
that were on average B300g heavier. The low-BMI mothers
also gave birth to only three LBW babies compared with six
LBW babies in the normal-BMI group (Table 1).
There was no significant group by trimester interaction for
any of the kinetic measurements or for plasma arginine and
NO concentrations (Table 2). There were significant main
effects of BMI and trimester for arginine flux when expressed
per unit of body weight. Flux was significantly faster
(Po0.01) in the low-BMI group compared with the normal-
BMI group in trimester 1 and there was a significant
reduction in arginine flux from trimester 1 to 2 in the low-
BMI group (Po0.01). When the data were expressed per unit
fat-free mass (FFM), however, only the effect of trimester was
significant. When expressed per whole body, this reduction
in arginine flux in the low-BMI group from trimester 1 to 2
did not achieve statistical significance. There were no
differences in the percent of arginine flux converted to NO
between groups in either trimester.
There was a significant main effect of trimester for
citrulline flux regardless of how the data were expressed, as
citrulline flux decreased significantly (Po0.001) in the low-
BMI group from trimester 1 to 2.
For plasma concentration of NO metabolites (NOx) there
was a significant main effect of BMI as concentration was
significantly higher (Po0.05) in the low-BMI group at
trimester 2. NOx concentration did not change from
trimester 1 to 2 in the low-BMI group, but there was a trend
toward a lower concentration in the normal-BMI group. The
rate of NO synthesis did not differ between groups and
trimesters, but in trimester 2 it was B50–60% greater in the
low-BMI group compared with the normal-BMI group
regardless of how the data were expressed.
Systolic blood pressure (SBP) was not different between the
low-BMI and normal-BMI groups in either trimester, and it
did not change significantly from trimester 1 to 2 (Table 2).
With respect to diastolic blood pressure (DBP), there was a
significant main effect of BMI regardless of trimester, as DBP
was significantly lower (Po0.05) in the low-BMI group
compared with the normal-BMI group.
The pooled data of all subjects (n¼20) were used to look
for correlations among arginine kinetic variables, rate of NO
synthesis, blood pressure, maternal variables, gestational age
and birth weight. In trimester 1, there were significant
negative correlations between arginine flux and maternal
weight and BMI (Table 3). BMI also correlated positively with
SBP and DBP. Birth weight correlated (positively) with only
one kinetic parameter, citrulline flux.
In trimester 2, there were significant negative correlations
between maternal weight and BMI and rate of NO synthesis
as well as between BMI and arginine flux. BMI also correlated
Table 2 Maternal arginine, citrulline and NO kinetics and blood pressures at the end of first and second trimesters
Plasma variable First trimester Second trimester
Normal BMI Low BMI Normal BMI LOW BMI
Arginine concentration (mmol/l) 58.5±2.9 54.5±5.2 48.7±2.3 54.7±4.9
Arginine Ra
(mmol/kg per h)
a,b 50.2±2.0 63.1±3.4 45±2.4 50.3±2.3
(mmol/h) 2443±69 2674±160 2342±119 2317±117
(mmolkg/FFM per h)
b 70.7±2.5 81.3±4.8 67.5±3.3 70.3±3.2
Citrulline Ra
(mmol/kg per h)
b 6.62±0.46 7.69±0.35 5.9±0.3 5.8±0.3
(mmol/h)
b 324±25 325±14 304±17 266±10.5
(mmolkg/FFM per h)
b 9.8±0.78 10.6±0.48 8.8±0.44 7.9±0.3
NOx concentration (mmol/l)
a 38.9±4.1 41.0±4.2 30.0±1.9 44.2±5.3
NO synthesis
(mmol/kg per h) 0.184±0.029 0.249±0.048 0.143±0.021 0.233±0.034
(mmol/h) 9±1.5 10.3±1.9 7.3±1.0 10.6±1.4
(mmolkg/FFM per h) 0.259±0.041 0.319±0.060 0.212±0.030 0.325±0.045
%A r gRa to NO 0.38±0.07 0.40±0.08 0.31±0.04 0.47±0.07
SBP (mmHg) 105.5±8.5 100.1±9.1 104.0±9.7 101.9±7.4
DBP (mmHg)
a 68.2±6.4 60.1±5.0 65.8±7.5 60.4±5.0
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; FFM, fat-free mass; Ra, endogenous rate of appearance (production); SBP, systolic blood
pressure.
Values except SBP and DBP are mean±s.e., SBP and DBP are mean ±n¼10 per group; low BMI, BMIp18.5; normal BMI, BMI 418.5o25.
aSignificant main effect of BMI (low BMI compared with normal BMI, Po0.005).
bSignificant main effect of trimester (trimester 1 compared with trimester 2, Po0.01).
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tions between gestational age and arginine and NO fluxes.
Discussion
The purpose of this study was to determine whether there
were differences in the rate of production of arginine and its
conversion to NO in pregnant women with low BMI
compared with those with normal BMI. Our results indicate
that arginine flux was faster in pregnant women with low
BMI compared with those with normal BMI at the end of
trimester 1, but not at the end of trimester 2. NO synthesis
was not different between the groups and did not change
significantly from trimester 1 to 2, though on average it was
50% faster in the low-BMI group compared with the normal-
BMI group in trimester 2. This latter finding, plus the fact
that NO synthesis correlated negatively with maternal
weight and BMI whereas blood pressure positively correlated
with BMI, suggests but do not prove that BMI may be
influencing blood pressure through NO synthesis during
pregnancy.
In a previous study of healthy normal weight pregnant
women, we reported increased whole-body NO production
during mid-pregnancy (Goodrum et al., 2003), supporting
the findings of animal and in vitro studies that NO may be
one factor involved in expansion of the vascular compart-
ment (Sladek et al., 1997). If true, then the finding that
pregnant women with low BMI have lower blood pressure
(Miller et al., 2007) and a decreased risk of preeclampsia
(Sebire et al., 2001; Bodnar et al., 2005, 2007; Bhattacharya
et al., 2007) suggests that women with low BMI may have
faster NO synthesis than women with normal and high BMI.
At the end of trimester 2, though NO synthesis was not
statistically different between the groups, the low-BMI group
was synthesizing weight-specific NO at a rate that was
B50% faster than the normal-BMI group (Table 2). Further-
more, the total amount of NO made by the low-BMI group
was 45% greater than the amount made by the normal-BMI
group, though the low-BMI group weighed 12% less and had
5% less FFM than the normal-BMI group. This can only be
explained by a faster rate of NO synthesis by the women with
low BMI compared with those with normal BMI at the end of
trimester 2. Not surprisingly, plasma NOx concentration was
also higher in the women with low BMI at the end of
trimester 2. A closer examination of the data reveals that NO
synthesis and concentration trended lower from trimester 1
to 2 in the women with normal BMI. This trend, however,
was not present in the women with low BMI. As a matter of
fact at the whole-body level, the total amount of NO
produced by the low-BMI group at trimester 2 was almost
identical to the amount produced at trimester 1 (10.6±1.4 vs
10.3±1.9mmol/h), whereas in the normal-BMI group, total
NO produced decreased by 19% from trimester 1 to 2, from
9±1.5 to 7.3±1mmol/h, though this change was not
significant.
The lower blood pressure of the low-BMI group compared
with the normal-BMI group plus the negative correlation
between maternal BMI and NO synthesis and the positive
correlation between BMI and blood pressures at trimester 2
suggest that BMI may influence blood pressure through NO
synthesis. This may not represent a problem in women with
normal BMI who may still be producing sufficient NO to
facilitate maintenance of vascular expansion. This negative
correlation between maternal BMI and NO synthesis, how-
ever, suggests higher BMIs may lead to decreased production
of NO, and therefore may make overweight and obese
women more susceptible to pregnancy-induced hyperten-
sion. This may be the reason for the higher incidence of
hypertension in obese pregnant women (Baeten et al., 2001),
although this needs to be investigated in further studies. It
has been proposed that reduced availability of NO could
increase the release of NO-inhibited endothelin-1 leading to
vasoconstriction (Davidge 1998). Although it is generally
accepted that deficient placentation and poor uteroplacental
circulation underlie preeclampsia, several other factors
including higher concentrations of the vasoconstrictor
thromboxane, systemic inflammation and oxidative stress
may be contributing to its pathogenesis (Walsh et al., 1993;
Redman et al., 1999). The present finding of an association
between BMI, NO synthesis and blood pressure offers one
more possible explanation for the lower incidence of
preeclampsia among pregnant women with low BMI (Bodnar
et al., 2005, 2007); that is, women with low BMI may be able
to produce sufficient quantities of NO to counter the effects of
the increased vasoconstrictors associated with preeclampsia.
This may not be the case in women with BMIs 425kg/m
2.
In support of this argument, it has been reported that
compared with placebo, oral supplementation with arginine
for 3 weeks in women with preeclampsia lowered blood
Table 3 Correlations between different parameters in all (n¼20)
women
Parameters Pearson’s correlation r P-value
Trimester 1
Fat-free mass vs arginine Ra  0.40 0.081
BMI vs arginine Ra  0.59 0.005
DBP vs BMI 0.65 0.002
DBP vs fat-free mass 0.54 0.01
SBP vs BMI 0.53 0.02
SBP vs fat-free mass 0.50 0.02
Birth weight vs citrulline flux 0.44 0.05
Trimester 2
BMI vs arginine Ra  0.43 0.05
BMI vs nitric oxide Ra  0.45 0.04
Fat-free mass vs nitric oxide Ra  0.52 0.02
DBP vs BMI 0.59 0.006
DBP vs fat-free mass 0.54 0.02
Gestational age vs NO flux 0.4 0.08
Gestational age vs arginine flux 0.38 0.09
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure;
Ra, endogenous rate of appearance; SBP, systolic blood pressure.
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indicative of increased NO synthesis (Rytlewski et al., 2005).
An alternative explanation for the persistently high NO
production of the low-BMI group is that it is a compensatory
response because these women may be facing a persistent
constraint (such as increased vasoconstrictors) in intra-
vascular expansion that is not present in the normal-BMI
group. It has been shown, for example, that human
placental NOS activity and NO production are significantly
increased in preeclampsia and eclampsia than those
of normal pregnancy, suggesting a physiological adaptive
response to overcome the increased placental vascular
resistance (Shaamash et al., 2001).
In the present study, the lack of correlation between
arginine flux and NO synthesis was surprising, because in
our earlier study of healthy American women, we reported
concomitant increases in arginine flux and NO production at
mid-pregnancy (Goodrum et al., 2003). Even though both
extracellular and intracellular arginine concentrations far
exceed the saturation point of NOS, availability of arginine
seems to affect NO synthesis (Bruckdorfer 2005). Although
arginine flux was different in normal-BMI compared with
low-BMI women in trimester 1, NO synthesis rates were not
different. In trimester 2, NO synthesis seems higher in the
low-BMI group compared with the normal-BMI group, even
though arginine flux and plasma concentration were similar.
In the low-BMI group, arginine flux decreased from trimester
1 to 2, but NO production did not change. These results
demonstrate a lack of association between arginine produc-
tion and the rate of NO synthesis. It is possible that changes
in arginine production did not translate into differences in
NO production, because NO synthesis represents only a
small percentage of total arginine flux (less than 1% in both
groups at both time points).
Despite the lack of correlation between arginine and NO
fluxes, an interesting observation was that both had fairly
good (P¼0.08; 0.09), though not statistically significant
correlations with gestational age (Table 3), suggesting that
they may be influencing pregnancy outcome possibly by
promoting uterine quiescence longer (Shaamash et al., 2001).
Although arginine and NO fluxes did not correlate with baby
birth weight, it is interesting to note that the low-BMI group,
with faster arginine and NO fluxes in the second trimester,
gave birth to babies that were on average B300g heavier and
this group had just three LBW babies compared with six in
the normal-BMI group. Interestingly, trimester 1 citrulline
flux, a fraction of which is derived from arginine by the
NOS reaction, was also significantly correlated to baby
birth weight. These observations suggest that increased
NO may be improving delivery of nutrients to the fetus
possibly through improved placental perfusion (Maul et al.,
2003). These preliminary findings suggest the need
for a larger study to determine whether there is a real
association between arginine, citrulline and NO metabolism
and pregnancy outcome in this population of pregnant
women.
In the present study, NOx concentration in plasma was
higher in the low-BMI group than in the normal-BMI group
in the second trimester. This difference paralleled the
difference in NO synthesis, but overall, NOx concentrations
did not correlate with rates of NO synthesis. Many previous
studies on pregnancy have used plasma NOx level and
urinary NOx excretion as indirect measures of NO produc-
tion (Maul et al., 2003). However, sources of NOx, in
addition to production from NO synthesis (Helmke and
Duncan, 2007), may include diet and the environment,
and plasma concentrations will be affected by renal
clearance (Villalpando et al., 2006). These influences on
NOx levels may explain the differing findings of studies
using these indirect approaches to investigate NO kinetics
in pregnancy.
There are several limitations to this study. First, several
results approached but did not reach statistical significance.
This is likely the result of a type II error. This study was
conducted in India, and these results may not be general-
izable to Western populations. Because maternal under-
nutrition is a common problem in developing countries,
this study compared pregnant women with low vs normal
BMI, and did not include subjects with high BMI. Finally,
this study was designed to investigate only one of several
potential factors that may influence blood pressure during
pregnancy. Nevertheless, this study provides baseline knowl-
edge for further investigations into the relationship between
BMI and arginine, citrulline and NO metabolism with
pregnancy-related complications such as preeclampsia.
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